Alzamend Neuro (ALZN) Notes Payables (2020 - 2024)

Alzamend Neuro has disclosed Notes Payables across 4 years of filings, most recently posting $300714.0 for Q2 2024.

• In Q2 2024, Notes Payables changed N/A year-over-year to $300714.0; the TTM figure through Apr 2024 stood at $300714.0 (changed N/A YoY), while the FY2024 annual figure was $300714.0, changed N/A from the prior year.
• Notes Payables came in at $300714.0 for Q2 2024 at Alzamend Neuro, down from $989334.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $989334.0 in Q4 2022 to a low of $2082.0 in Q1 2022.
• Average Notes Payables over 4 years is $185069.9, with a median of $60749.0 recorded in 2021.
• The largest YoY upside for Notes Payables was 45240.7% in 2022 against a maximum downside of 96.57% in 2022.
• Over 4 years, Notes Payables stood at $62667.0 in 2020, then plunged by 96.52% to $2182.0 in 2021, then soared by 45240.7% to $989334.0 in 2022, then slumped by 69.6% to $300714.0 in 2024.
• Per Business Quant data, the three most recent Notes Payables figures were $300714.0 in Q2 2024, $989334.0 in Q4 2022, and $2082.0 in Q2 2022.